COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 2900: Articles 28991-29000  | Next

A Recursive Bifurcation Model for Predicting the Peak of COVID-19 Virus Spread in United States and Germany
Shen, J.
10.1101/2020.04.09.20059329 — Posted: 2020-04-14
COVID-19 in India: Predictions, Reproduction Number and Public Health Preparedness
Rai, B., Shukla, A., Dwivedi, L. K.
10.1101/2020.04.09.20059261 — Posted: 2020-04-14 Discussion: Onsite
A Scalable Method of Applying Heat and Humidity for Decontamination of N95 Respirators During the COVID-19 Crisis
Anderegg, L., Meisenhelder, C., Ngooi, C. O., Liao, L., Xiao, W., Chu, S., Cui, Y., Doyle, J. M.
10.1101/2020.04.09.20059758 — Posted: 2020-04-14
Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)
Ai, J., Gong, J., Xing, L., He, R., Tian, F., Wang, J., Wang, J., Pei, S. P., Chen, D., Huang, G., Zhang, M., Qu, G., Fan, W., Lin, H., Li, D., Pei, B.
10.1101/2020.04.09.20059352 — Posted: 2020-04-14 Discussion: Onsite
Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials
Gebrie, D., Getnet, D., Manyazewal, T.
10.1101/2020.04.09.20059196 — Posted: 2020-04-14
Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes.
Corley, M. J., Sugai, C., Schotsaert, M., Schwartz, R. E., Ndhlovu, L. C.
10.1101/2020.04.13.039263 — Posted: 2020-04-14
CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic
Akther, S., Bezrucenkovas, E., Sulkow, B., Panlasigui, C., Li, L., Qiu, W., Di, L.
10.1101/2020.04.10.036343 — Posted: 2020-04-14
High-surety isothermal amplification and detection of SARS-CoV-2, including with crude enzymes
Bhadra, S., Riedel, T. E., Lakhotia, S., Tran, N. D., Ellington, A. D.
10.1101/2020.04.13.039941 — Posted: 2020-04-14 Discussion: Onsite
Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics
Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Nurani, A., Zhu, D. Y., Goyal, G., Gilpin, S., Prantil-Baun, R., Ingber, D. E.
10.1101/2020.04.13.039917 — Posted: 2020-04-14 Discussion: Offsite
Single Nucleus Multiomic Profiling Reveals Age-Dynamic Regulation of Host Genes Associated with SARS-CoV-2 Infection
Wang, A., Chiou, J. A., Poirion, O. B., Buchanan, J., Valdez, M. J., Verheyden, J. M., Hou, X., Guo, M., Newsome, J. M., Kudtarkar, P., Faddah, D. A., Zhang, K., Young, R. E., Barr, J., Misra, R., Huyck, H., Rogers, L., Poole, C., Whitsett, J. A., Pryhuber, G., Xu, Y., Gaulton, K. J., Preissl, S., Sun, X., NHLBI LungMap Consortium
10.1101/2020.04.12.037580 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).